Wixela vs Trelegy
What to choose Wixela or Trelegy
Wixela is inhaler of type Control while Trelegy is of Control type. Wixela and Trelegy are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Trelegy is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg.
The average price for Wixela is approximately $240 while average cost for Trelegy is roughly $619.92, said Levi Hall, a Research Assistant at the Pembroke State University and a Medical Director at a clinic that uses Wixela and Trelegy.
Wixela and Trelegy Comparison
| Wixela | Trelegy | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Viatris | GSK |
| Substance: | Fluticasone + Salmeterol | Fluticasone + Vilanterol |
| Dosage: | 250/50 | 100 mcg / 25 mcg |
| Avg Price: | $240 | $619.92 |